[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Tenaya Therapeutics Inc (TNYA)

Tenaya Therapeutics Inc (TNYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Tenaya Therapeutics Inc 171 OYSTER POINT BOULEVARD SUITE 500 SOUTH SAN FRANCISCO CA 94080 USA

www.tenayatherapeutics.com Employees: 70 P: 650-825-6990

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Tenaya Therapeutics Inc. is a biotechnology company. It discovers, develop and deliver curative therapies which address the underlying causes of heart disease. The company's product platform consist Gene Therapy, Cellular Regeneration and Precision Medicine. Tenaya Therapeutics Inc. is based in SOUTH SAN FRANCISCO, Calif.

Key Statistics

Overview:

Market Capitalization, $K 156,356
Enterprise Value, $K 55,806
Shares Outstanding, K 224,230
Float, K 218,557
% Float 97.47%
Short Interest, K 21,988
Short Float 9.81%
Days to Cover 13.74
Short Volume Ratio 0.54
% of Insider Shareholders 2.53%
% of Institutional Shareholders 90.54%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -90,600 K
Last Quarter Sales, $ 1,110 K
Last Quarter Net Income, $ -43,390 K
EBIT, $ -105,880 K
EBITDA, $ -97,030 K

Growth:

1-Year Return -39.53%
3-Year Return -83.63%
5-Year Return -97.38%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.09 on 08/05/26
Next Earnings Date 11/09/26
Earnings Per Share ttm -0.42
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year 35.71%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

TNYA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -83.75%
Return-on-Assets % -66.53%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales 100.89
Price/Cash Flow N/A
Price/Book 2.23
Book Value/Share 0.32
Interest Coverage -2.67
60-Month Beta 2.83
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.